Skip to Main Content
Table 1

Patient characteristics on admission

Insulin analogs (glulisine/glargine)Human insulin (NPH/regular)
n 34 34 
Age (years) 39 ± 12 38 ± 12 
Sex (male/female) 22/12 23/11 
Race   
    African American 29 27 
    Caucasian 
    Other  
BMI (kg/m229 ± 9 27 ± 7 
Precipitating cause of DKA   
    Poor compliance 20 (59) 27 (79) 
    New-onset diabetes 6 (18)  
    Other medical illness 8 (23) 7 (21) 
Glucose (mg/dl) 529 ± 173 564 ± 164 
Bicarbonate (mEq/l) 12.8 ± 4.5 12.5 ± 5.0 
Venous pH 7.2 ± 0.1 7.1 ± 0.2 
Anion gap (mEq/l) 22 ± 6 22 ± 6 
β-Hydroxybutyrate (mmol/l) 8.0 ± 3.4 7.4 ± 3.3 
A1C (%) 11.7 ± 2.2 11.7 ± 2.9 
Insulin analogs (glulisine/glargine)Human insulin (NPH/regular)
n 34 34 
Age (years) 39 ± 12 38 ± 12 
Sex (male/female) 22/12 23/11 
Race   
    African American 29 27 
    Caucasian 
    Other  
BMI (kg/m229 ± 9 27 ± 7 
Precipitating cause of DKA   
    Poor compliance 20 (59) 27 (79) 
    New-onset diabetes 6 (18)  
    Other medical illness 8 (23) 7 (21) 
Glucose (mg/dl) 529 ± 173 564 ± 164 
Bicarbonate (mEq/l) 12.8 ± 4.5 12.5 ± 5.0 
Venous pH 7.2 ± 0.1 7.1 ± 0.2 
Anion gap (mEq/l) 22 ± 6 22 ± 6 
β-Hydroxybutyrate (mmol/l) 8.0 ± 3.4 7.4 ± 3.3 
A1C (%) 11.7 ± 2.2 11.7 ± 2.9 

Data are means ± SD or n (%).

Close Modal

or Create an Account

Close Modal
Close Modal